GlassScriptPhysician profile
Farah Khatoon
NPI 1639356108
$17,838.66
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,568 · 2020: $732 · 2021: $94.56 · 2022: $194 · 2023: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $22.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,228.43 |
| Food and Beverage | $22.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $10,228.43 | 2023 | |
| Alexion Pharmaceuticals, INC. | $7,024.09 | 2019-2022 | |
| Abbvie INC. | $73.94 | 2019-2023 | |
| Novo Nordisk INC | $64.09 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $55.27 | 2021-2022 | |
| Dexcom, INC. | $55.21 | 2019-2020 | |
| Abbott Laboratories | $49.99 | 2019 | |
| Ascendis Pharma Endocrinology INC | $49.95 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $44.89 | 2019-2022 | |
| Insulet Corporation | $42.14 | 2019-2022 | |
| Tandem Diabetes Care, INC. | $28.99 | 2022 | |
| Ferring Pharmaceuticals INC. | $27.82 | 2019 | |
| Medtronic Minimed, INC. | $25.15 | 2019 | |
| Biomarin Pharmaceutical INC. | $19.46 | 2022 | |
| Medtronic, INC. | $18.77 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $17.21 | 2019 | |
| Lilly USA, LLC | $13.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farah Khatoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.